GlassScriptPhysician profile
Amy O Thomas
NPI 1134359862
$833.12
in general payments reported to CMS, 2019-2025
9 companies · $55.73 in 2025
The $55.73 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.73 · 2022: $224 · 2023: $174 · 2024: $331 · 2025: $55.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $219.83 | 2022-2024 | |
| Glaxosmithkline, LLC. | $211.18 | 2022-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $126.62 | 2021-2024 | Dupixent |
| Sanofi-Aventis U.S. LLC | $65.37 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $62.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $55.73 | 2025 | |
| Genentech USA, INC. | $37.65 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.85 | 2021-2022 | |
| Alk-Abello, INC | $17.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.